what glp 1 does hers use Novo Nordisk Drops Hims & Hers: Inside the Compounded GLP-1 Crisis Weight Loss Care for Women,

More recently, longer-acting and more potent GLP-1 analogs have been developed, most notably semaglutide, which received FDA approval for type 2 diabetes in 2017

GLP-1s often work better for both goals

Physiology & Behavior

Appetite suppression and lower calorie intake without a robust protein and strength program can lead to disproportionate lean mass loss, which reduces resting metabolic rate, functional strength, and glucose disposal capacity

Gas and bloating (especially after diet changes) Bloating on GLP-1s is often a three-part story: slowed transit, new foods (protein products, bars, sugar alcohols), and fermentation

These signals included dizziness (ROR, 1.30, 95% CI 1.271.33), tremor (1.37, 1.321.42), dysgeusia (1.72, 1.641.81), lethargy (1.24, 1.151.33), taste disorder (2.55, 2.332.80), presyncope (1.39, 1.251.54), parosmia (2.39, 2.072.75), allodynia (25.55, 21.7130.08), hypoglycemic unconsciousness (8.11, 6.949.46), brain fog (1.78, 1.512.10), hyperesthesia (1.40, 1.181.66), diabetic neuropathy (1.95, 1.612.36), hypoglycemic seizure (3.29, 2.324.66), ophthalmic migraine (3.14, 1.885.27), Wernickes encephalopathy (2.37, 1.394.04), diabetic hyperglycemic coma (3.07, 1.685.62), hyperglycemic unconsciousness (7.94, 4.2714.77), vagus nerve disorder (3.75, 1.927.32), and hyperglycemic seizure (5.85, 1.8118.90) (Fig